Quarterly report pursuant to Section 13 or 15(d)

3. ACQUISITION OF AVENTINE (Details - Pro forma)

v3.2.0.727
3. ACQUISITION OF AVENTINE (Details - Pro forma) - Aventine - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Revenues - pro forma $ 390,224 $ 466,599 $ 727,337 $ 838,475
Net income (loss) - pro forma $ (9,428) $ 26,153 $ (28,768) $ 5,022
Diluted net income (loss) per share - pro forma $ (0.22) $ 0.65 $ (0.68) $ 0.13
Diluted weighted-average shares - pro forma 42,596,000 40,035,000 42,348,000 38,273,000